What's in Instituto de Investigación Sanitaria Aragón's pipeline?

Instituto de Investigación Sanitaria Aragón has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Instituto de Investigación Sanitaria Aragón's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, B&A Therapeutics, China National Center for Cardiovascular Diseases, Ferrer Internacional S.A., Heart Care Foundation.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/instituto-de-investigaci-n-sanitaria-arag-n.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Instituto de Investigación Sanitaria Aragón — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Instituto de Investigación Sanitaria Aragón pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Furosemide 20 Milligrams	Furosemide 20 Milligrams	phase 3	Loop diuretic	Na-K-2Cl cotransporter (NKCC2)	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
B&A Therapeutics · 1 shared drug class
China National Center for Cardiovascular Diseases · 1 shared drug class
Ferrer Internacional S.A. · 1 shared drug class
Heart Care Foundation · 1 shared drug class
Jose J Zaragoza, MD MSc · 1 shared drug class
Lakeland Regional Health Systems, Inc. · 1 shared drug class
Aspirus Heart and Vascular Institute-Research and Education · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Instituto de Investigación Sanitaria Aragón:

Cite this brief

Drug Landscape (2026). Instituto de Investigación Sanitaria Aragón — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/instituto-de-investigaci-n-sanitaria-arag-n. Accessed 2026-05-17.